Steven Caltrider is a 2024 Massachusetts Lawyers Weekly In-House Leader

Posted date

Steven Caltrider has been selected as one of the 2024 In-House Leaders in the Law by Massachusetts Lawyers Weekly. In-House Leaders are general counsel and staff attorneys who are nominated by their colleagues, clients, and other legal professionals for being leaders in the in-house community and forward thinkers.

Caltrider is currently Vice President and Chief Intellectual Property Officer at Dana-Farber Cancer Institute, where he advises on the complexities of a global patent landscape, including U.S. and foreign procurement, litigation, and licensing matters. Prior to joining Dana-Farber, Caltrider served as Vice President and General Patent Counsel for Eli Lilly and Company before retiring after 34 years of service. He also serves as Chair of the American Bar Association Section of Intellectual Property and is former chair of the United States Public Patent Advisory Committee (PPAC).

In each of these roles, Caltrider has consistently demonstrated his dedication: first, to enhancing intellectual property laws in support of innovation — a vital component for tomorrow's medical breakthroughs benefiting patients at Dana-Farber, as well as bolstering American prosperity; and second, to nurturing the next generation of outstanding legal professionals. He frequently emphasizes the importance for IP practitioners not to stretch the limits of IP laws to their breaking point, but rather to advocate for clients fervently while upholding and fortifying the patent system's constitutional duty to promote the arts.

Caltrider received a bachelor's degree in chemical engineering from Purdue University and a law degree, summa cum laude, from the Indiana University Robert H. McKinney School of Law.

Caltrider will be honored with the other Lawyers Weekly honorees at a gala celebration in Boston, MA, on May 21.

View a full list of the 2024 Lawyers Weekly honorees.

Media Contacts

If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email

The Media Team cannot respond to patient inquiries. For more information, please see Contact Us.


Steven Caltrider